June 13, 2013
Dainippon Sumitomo Pharma (DSP) and Shionogi announced on June 12 that the companies launched on the same day their new dosage form of Avapro Tablets 200 mg and Irbetan Tablets 200 mg (irbesartan), a long-acting angiotensin receptor antagonist (ARB). The...read more